Table 2.
Univariate HRs for lymphoid malignancy and all malignancies (excluding lymphoid malignancy) among patients and controls
| Total | Patients with herpes zoster | Matched-control subjects | |
|---|---|---|---|
| Presence of lymphoid malignancy |
|
|
|
| Yes, no. (%) of patients |
154 (0.07) |
48 (0.11) |
106 (0.06) |
| No, no. (%) of patients |
212,105 (99.93) |
42,348 (99.89) |
169,757 (99.94) |
| Univariate HRa (95% CI) |
- |
1.82 (1.29-2.55) |
Reference |
|
P value |
|
0.0006 |
|
| Presence of cancer (excluded lymphoid malignancy) |
|
|
|
| Yes, no. (%) of patients |
4,865 (2.29) |
1,027 (2.42) |
3,838 (2.26) |
| No, no. (%) of patients |
207,590 (97.71) |
41,458 (97.58) |
166,132 (97.74) |
| Univariate HRa (95% CI) |
- |
1.07 (1.01-1.15) |
Reference |
| P value | 0.0465 |
aHR: Hazard ratio.